Revisiting Estrogen: Efficacy and Safety for Postmenopausal Bone Health
The rapid decline in endogenous estrogen production that occurs during menopause is associated with significant bone loss and increased risk for fragility fracture. While hormone therapy (HT) is an effective means to re-establish endogenous estrogen levels and reduce the risk of future fracture, its...
Saved in:
Main Authors: | Sandra M. Sacco, Wendy E. Ward |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Journal of Osteoporosis |
Online Access: | http://dx.doi.org/10.4061/2010/708931 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress on the correlation between estrogen and estrogen receptor on postmenopausal sarcopenia
by: Chengmei Zhang, et al.
Published: (2024-11-01) -
Antiosteoporotic activity of lupeol on postmenopausal symptoms through promoting estrogenic activity and bone markers in ovariectomized rats
by: Tanmayee Bhalerao, et al.
Published: (2024-11-01) -
Relationship between Postmenopausal Estrogen Deficiency and Aneurysmal Subarachnoid Hemorrhage
by: Sadaharu Tabuchi
Published: (2015-01-01) -
Exploration of the metabolomic mechanisms of postmenopausal hypertension induced by low estrogen state
by: Yao Li, et al.
Published: (2025-01-01) -
Progranulin deficiency associates with postmenopausal osteoporosis via increasing ubiquitination of estrogen receptor α
by: Guangfei Li, et al.
Published: (2025-01-01)